GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus

2021 ◽  
pp. 104998
Author(s):  
Ajay Manaithiya ◽  
Ozair Alam ◽  
Vrinda Sharma ◽  
Mohd. Javed Naim ◽  
Shruti Mittal ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Therapeutic Agents ◽  
Novel Therapeutic

scholarly journals Circadian Etiology of Type 2 Diabetes Mellitus

Physiology ◽  
2018 ◽  
Vol 33 (2) ◽  
pp. 138-150 ◽  
Author(s):  
Naureen Javeed ◽  
Aleksey V. Matveyenko
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Circadian System ◽  
Therapeutic Targeting ◽  
Treatment And Prevention ◽  
Metabolic Comorbidities ◽  
Novel Therapeutic

The epidemic of Type 2 diabetes mellitus necessitates development of novel therapeutic and preventative strategies to attenuate expansion of this debilitating disease. Evidence links the circadian system to various aspects of diabetes pathophysiology and treatment. The aim of this review will be to outline the rationale for therapeutic targeting of the circadian system in the treatment and prevention of Type 2 diabetes mellitus and consequent metabolic comorbidities.

scholarly journals Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus

Adipocyte ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 48-65
Author(s):  
Long Cheng ◽  
Jingkang Wang ◽  
Hongyu Dai ◽  
Yuhui Duan ◽  
Yongcheng An ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Adipose Tissue ◽  
Therapeutic Strategy ◽  
Beige Adipose Tissue ◽  
Novel Therapeutic
Sign in / Sign up

Export Citation Format

Share Document